Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes in the United Kingdom and Germany: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes in the United Kingdom and Germany: A Retrospective Cohort Study

Published:2023-06-07 Issue:8 Volume:40 Page:3446-3464
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Barrett Annabel,Debackere Nele,Ribeiro Anderson,Keapoletswe Karabo,Zingel Rebecca,Coles Briana

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02540-y.pdf

Reference29 articles.

1. International Diabetes Federation. IDF Diabetes Atlas 10th edition. 2021. IDF_Atlas_10th_Edition_2021.pdf. IDF Diabetes Atlas 2021 | IDF Diabetes Atlas. Accessed 26 Oct 2022.

2. Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20:546–51.

3. Landgrave R, Kellerer M, Fach E, et al. Practical recommendations DDG/DGIM: treatment of type 2 diabetes. https://www.researchgate.net/publication/285804464_Practical_recommendations_of_the_DDGDGIM_Treatment_of_type_2_diabetes. Accessed 26 Oct 2022.

4. National Institute for Health and Care Excellence. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28. Accessed 26 Oct 2022.

5. Trulicity (dulaglutide). European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/trulicity. Accessed 26 Oct 2022.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Letter];Diabetes, Metabolic Syndrome and Obesity;2024-04

2. German longitudinal prescription database (LRx): Description of characteristics, use in pharmacoepidemiological research, and limitations;Int. Journal of Clinical Pharmacology and Therapeutics;2024-01-01